EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Duplex ultrasound after endo revascularisation (DUSTER): protocol for a randomised controlled feasibility trial

Nishita Gadi, Carmel Moore, Karen Hayden, Jufen Zhang, Georgina Beetar, Steven Rogers, Clayre Smith-Ball, Alun Davies, Ankur Thapar

BMJ Open · 2025

DOI: 10.1136/bmjopen-2025-101137 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift BMJ Open, 2025. Verfasst von Nishita Gadi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Mid and South Essex Vascular Unit, Mid and South Essex NHS Foundation Trust, Basildon, Essex, UK. Hauptthemen laut MEDLINE: Ultrasonography, Doppler, Duplex, Endovascular Procedures, Lower Extremity, Ischemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research for Patient Benefit Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction Endovascular therapy is the main treatment for chronic limb-threatening ischaemia in the UK. Despite a restenosis risk of 50% over 2 years, reintervention rates are low, potentially resulting in preventable amputations. European guidelines recommend ultrasound surveillance to facilitate early treatment of restenosis. This study will investigate the use of duplex ultrasound after endo revascularisation (DUSTER). The aim is to assess the feasibility, acceptability and impact on clinical decision-making of a 1-year integrated ultrasound surveillance programme after lower limb endovascular therapy. Methods and analysis DUSTER is a mixed-methods study. Phase I is a three-site, feasibility, open-label, randomised controlled trial. The standard of care, the control arm, is standard clinical surveillance by a vascular specialist at 1, 6 and 12 months. The intervention arm will receive integrated ultrasound (ankle-brachial pressure index, toe pressure and duplex) plus standard clinical surveillance. Primary outcomes are rates of attendance and completion of ultrasound surveillance tests, as well as the percentage of participants undergoing reintervention for restenosis. Secondary outcomes are limb salvage, amputation-free survival, reasons for amputation, complications, serious adverse events and mortality. Phase II comprises independent semistructured interviews with intervention arm participants. The interviews will explore barriers and facilitators to ultrasound surveillance and the effect of ultrasound surveillance on patients’ lives. Phase III has two separate focus groups for participants and clinical stakeholders to identify which outcomes matter most in any subsequent large-scale effectiveness trials. Ethics and dissemination This research has been approved by a UK (West Midlands, Black Country) Research Ethics Committee (reference 24/WM/0232) and the Health Research Authority (IRAS 349192). Dissemination of results will be by the DUSTER co-investigators in peer-reviewed journals, to the National Institute for Health and Care Research and to a lay audience via the Mid and South Essex NHS Foundations Trust website. Trial registration number NCT06702306 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ultrasonography, Doppler, DuplexEndovascular ProceduresLower ExtremityIschemiaPeripheral Arterial DiseaseHumansFeasibility StudiesRandomized Controlled Trials as TopicLimb SalvageAmputation, SurgicalAnkle Brachial Index

Stichwörter der Autor:innen

Follow-Up StudiesUltrasoundVASCULAR SURGERY

Autor:innen und Institutionen

  • Mid and South Essex Vascular Unit, Mid and South Essex NHS Foundation Trust, Basildon, Essex, UK.
  • Clinical Trials Unit, Anglia Ruskin University, Chelmsford, Essex, UK.
  • Manchester Academic Health Science Centre, Manchester, UK.
  • Manchester University NHS Foundation Trust, Manchester, UK.
  • The Limbless Association, Basildon, England, UK.
  • Department of Vascular Surgery, Imperial College London, London, UK.

Förderung

  • Research for Patient Benefit Programme

Zitieren

APA

Gadi, N., Moore, C., Hayden, K., Zhang, J., Beetar, G., Rogers, S., Smith-Ball, C., Davies, A., & Thapar, A. (2025). Duplex ultrasound after endo revascularisation (DUSTER): protocol for a randomised controlled feasibility trial. BMJ Open. https://doi.org/10.1136/bmjopen-2025-101137

Vancouver

Gadi N, Moore C, Hayden K, Zhang J, Beetar G, Rogers S, et al. Duplex ultrasound after endo revascularisation (DUSTER): protocol for a randomised controlled feasibility trial. BMJ Open. 2025. doi:10.1136/bmjopen-2025-101137

BibTeX
@article{Gadi2025,
  author = {Gadi, Nishita and Moore, Carmel and Hayden, Karen and Zhang, Jufen and Beetar, Georgina and Rogers, Steven and Smith-Ball, Clayre and Davies, Alun and Thapar, Ankur},
  title = {Duplex ultrasound after endo revascularisation (DUSTER): protocol for a randomised controlled feasibility trial},
  journal = {BMJ Open},
  year = {2025},
  doi = {10.1136/bmjopen-2025-101137}
}
Kostenlos starten →